X-Nico

unusual facts about Chromosome 9



Lethal congenital contracture syndrome

The defective gene associated with LCCS1 is mRNA export mediator GLE1 at chromosome 9q34.


see also

Personalized medicine

Tyrosine kinase inhibitors such as imatinib (marketed as Gleevec) have been developed to treat chronic myeloid leukemia (CML), in which the BCR-ABL fusion gene (the product of a reciprocal translocation between chromosome 9 and chromosome 22) is present in >95% of cases and produces hyperactivated abl-driven protein signaling.